BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36949950)

  • 1. Mass cytometry identifies characteristic immune cell subsets in bronchoalveolar lavage fluid from interstitial lung diseases.
    Hata K; Yanagihara T; Matsubara K; Kunimura K; Suzuki K; Tsubouchi K; Eto D; Ando H; Uehara M; Ikegame S; Baba Y; Fukui Y; Okamoto I
    Front Immunol; 2023; 14():1145814. PubMed ID: 36949950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
    Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
    Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The expression and clinical role of KL-6 in serum and BALF of patients with different diffuse interstitial lung diseases].
    Zhu C; Zhao YB; Kong LF; Li ZH; Kang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb; 39(2):93-7. PubMed ID: 26879611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-9 and IL-9 receptor expression in lymphocytes from bronchoalveolar lavage fluid of patients with interstitial lung disease.
    Jehn LB; Costabel U; Boerner E; Wessendorf TE; Theegarten D; Taube C; Bonella F
    Immunobiology; 2022 Sep; 227(5):152258. PubMed ID: 35998415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases.
    Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Skibova J; Striz I
    Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mRNA expression profile of bronchoalveolar lavage fluid cells from patients with idiopathic pulmonary fibrosis and sarcoidosis.
    Paplińska-Goryca M; Goryca K; Misiukiewicz-Stępień P; Nejman-Gryz P; Proboszcz M; Górska K; Maskey-Warzęchowska M; Krenke R
    Eur J Clin Invest; 2019 Sep; 49(9):e13153. PubMed ID: 31246273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases.
    Vogt S; Trendelenburg M; Tamm M; Stolz D; Hostettler KE; Osthoff M
    Front Immunol; 2020; 11():562564. PubMed ID: 33101280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Pepsin in Bronchoalveolar Lavage Fluid and Prognosis of Chronic Fibrosing Interstitial Lung Disease.
    Kim Y; Lee YJ; Cho YJ; Yoon HI; Lee JH; Lee CT; Park JS
    Tohoku J Exp Med; 2018 Nov; 246(3):147-153. PubMed ID: 30405002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
    Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
    Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and bronchoalveolar lavage fluid levels of soluble B7H3 in patients with interstitial lung diseases.
    Nakashima T; Omori K; Namba M; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Respir Med; 2023 Jun; 212():107224. PubMed ID: 37003499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of S100A9 and KL-6 in common interstitial lung diseases.
    Lin L; Zhao Y; Li Z; Li Y; Wang W; Kang J; Wang Q
    Medicine (Baltimore); 2022 Apr; 101(17):e29198. PubMed ID: 35512076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
    de Lauretis A; Veeraraghavan S; Renzoni E
    Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchoalveolar Lavage Lymphocytes in the Diagnosis of Hypersensitivity Pneumonitis among Patients with Interstitial Lung Disease.
    Patolia S; Tamae Kakazu M; Chami HA; Chua A; Diaz-Mendoza J; Duggal A; Jenkins AR; Knight SL; Raghu G; Wilson KC
    Ann Am Thorac Soc; 2020 Nov; 17(11):1455-1467. PubMed ID: 32757946
    [No Abstract]   [Full Text] [Related]  

  • 14. Exploratory mass cytometry analysis reveals immunophenotypes of cancer treatment-related pneumonitis.
    Yanagihara T; Hata K; Matsubara K; Kunimura K; Suzuki K; Tsubouchi K; Ikegame S; Baba Y; Fukui Y; Okamoto I
    Elife; 2024 Apr; 12():. PubMed ID: 38607373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated approach to bronchoalveolar lavage cytology to distinguish interstitial lung diseases.
    Bergantini L; d'Alessandro M; Cameli P; Perrone A; Cekorja B; Boncompagni B; Mazzei MA; Sestini P; Bargagli E
    Eur J Intern Med; 2021 Jul; 89():76-80. PubMed ID: 33931268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchoalveolar Lavage Fluid Reflects a T
    Friedmann D; Unger S; Keller B; Rakhmanov M; Goldacker S; Zissel G; Frye BC; Schupp JC; Prasse A; Warnatz K
    Front Immunol; 2020; 11():616832. PubMed ID: 33613543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of respiratory virus detection in patients with acute exacerbation of interstitial lung diseases.
    Saraya T; Kimura H; Kurai D; Tamura M; Ogawa Y; Mikura S; Sada M; Oda M; Watanabe T; Ohkuma K; Inoue M; Honda K; Watanabe M; Yokoyama T; Fujiwara M; Ishii H; Takizawa H
    Respir Med; 2018 Mar; 136():88-92. PubMed ID: 29501253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAL biomarkers' panel for differential diagnosis of interstitial lung diseases.
    d'Alessandro M; Carleo A; Cameli P; Bergantini L; Perrone A; Vietri L; Lanzarone N; Vagaggini C; Sestini P; Bargagli E
    Clin Exp Med; 2020 May; 20(2):207-216. PubMed ID: 31970550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
    Suga M; Iyonaga K; Ichiyasu H; Saita N; Yamasaki H; Ando M
    Eur Respir J; 1999 Aug; 14(2):376-82. PubMed ID: 10515417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of lymphocyte immune phenotypes in bronchoalveolar lavage of non-smoking patients with sarcoidosis and other interstitial lung diseases.
    Novosadova E; Navratilova Z; Ordeltova M; Zurkova M; Zatloukal J; Kolek V; Petrek M
    J Thorac Dis; 2019 Jun; 11(6):2287-2296. PubMed ID: 31372265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.